The organoid era permits the development of new applications to study glioblastoma

23Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Glioblastoma (GB) is the most frequent and aggressive type of glioma. The lack of reliable GB models, together with its considerable clinical heterogeneity, has impaired a comprehensive investigation of the mechanisms that lead to tumorigenesis, cancer progression, and response to treatments. Recently, 3D cultures have opened the possibility to overcome these challenges and cerebral organoids are emerging as a leading-edge tool in GB research. The opportunity to easily engineer brain organoids via gene editing and to perform co-cultures with patient-derived tumor spheroids has enabled the analysis of cancer development in a context that better mimics brain tissue architecture. Moreover, the establishment of biobanks from GB patient-derived organoids represents a crucial starting point to improve precision medicine therapies. This review exemplifies relevant aspects of 3D models of glioblastoma, with a specific focus on organoids and their involvement in basic and translational research.

Cite

CITATION STYLE

APA

Andreatta, F., Beccaceci, G., Fortuna, N., Celotti, M., Felice, D. D., Lorenzoni, M., … Alaimo, A. (2020, November 1). The organoid era permits the development of new applications to study glioblastoma. Cancers. MDPI AG. https://doi.org/10.3390/cancers12113303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free